John Schorge, MD, associate editor of The Green Journal, and Gynecologic Oncologist at Tufts Medical Center, discusses the findings of his study on neoadjuvant chemotherapy treatment of patients with advanced ovarian cancer.
John Schorge, MD, associate editor of The Green Journal, and Gynecologic Oncologist at Tufts Medical Center, discusses the findings of his study on neoadjuvant chemotherapy treatment of patients with advanced ovarian cancer.
Transcript
What were the findings of your study that investigated the delivery of neoadjuvant chemotherapy to women with advanced ovarian cancer?
One of the conundrums and controversies in the field is people that present with ovarian cancer— two-thirds of the time it's fairly advanced. Whether to start with surgery first or chemotherapy first has been the dilemma.
Historically, people have started with surgery first, and yet over the last decade or so there's been a lot more evidence that starting with chemotherapy— such as neoadjuvant chemotherapy, which means chemo first– seems to work out just as well in the long run in many cases.
Part of our work was looking at that trend and then determining that as an interval operation— which means halfway through the chemotherapy– if you're able to do a minimally invasive operation, like a standard laparoscopy, people have similar outcomes to open surgery, and a lot fewer side effects and a lot less complication risk.
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More